Shallal, Hassan M.; Faridi, Jesika S.; Russu, Wade A. published the artcile< Anti-tumor pyrimidinylpiperazines bind to the prosurvival Bcl-2 protein family member Bcl-XL>, Product Details of C13H19BrN4O2, the main research area is pyrimidinylpiperazine preparation Bcl XL protein inhibitor anticancer; piperazine pyrimidinyl preparation Bcl XL protein inhibitor anticancer.
Overexpression of prosurvival or underexpression of pro-death Bcl-2 family proteins can lead to cancer cell resistance to chemotherapy and radiation treatment. Inhibition of the prosurvival Bcl-2 family proteins has become a strategy for cancer therapy and inhibitors are currently being evaluated in the clinic both as single agents and in combination with established drugs. Here, we describe the design, synthesis, and evaluation of pyrimidinylpiperazines I (R = Et, X = H, F, OH, NO2, Y = H, Br, Cl, 1H-pyrazol-4-yl; R = PhCH2, X = H, F, OH, NO2, NH2, Y = H, Br, Cl, 1H-pyrazol-4-yl) that were discovered to be inhibitors of the prosurvival Bcl-2 protein family member Bcl-XL. This study identified compound I (R = PhCH2, X = H, Y = 1H-pyrazol-4-yl), which demonstrated a GI50 value of 8.4 μM against A549 lung adenocarcinoma cells and a binding affinity Ki value for Bcl-XL of 127 nM.
Bioorganic & Medicinal Chemistry Letters published new progress about Antitumor agents. 374930-88-8 belongs to class piperazines, and the molecular formula is C13H19BrN4O2, Product Details of C13H19BrN4O2.
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics